Biohaven Ltd.
BHVN
$8.28
-$0.10-1.14%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -145.56M | -173.44M | -198.15M | -221.68M | -186.84M |
| Total Depreciation and Amortization | 2.57M | 3.13M | 1.98M | 2.25M | 2.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.15M | 27.61M | 9.68M | 58.67M | 19.66M |
| Change in Net Operating Assets | -9.83M | -3.01M | 18.56M | -4.37M | -6.02M |
| Cash from Operations | -130.66M | -145.72M | -167.94M | -165.12M | -170.74M |
| Capital Expenditure | -8.00K | -13.00K | -233.00K | -461.00K | -49.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 391.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.73M | 164.98M | -15.31M | 165.34M | -88.02M |
| Cash from Investing | -13.74M | 164.97M | -15.55M | 164.88M | -87.68M |
| Total Debt Issued | 0.00 | 0.00 | 250.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 189.44M | 122.00K | 1.08M | 369.00K | 274.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -644.00K | 0.00 | -1.25M | -- | -1.35M |
| Cash from Financing | 188.80M | 122.00K | 249.83M | 369.00K | 272.85M |
| Foreign Exchange rate Adjustments | 0.00 | 14.00K | -40.00K | 23.00K | 88.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.40M | 19.39M | 66.31M | 147.00K | 14.52M |